Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04319471
What this trial is testing

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 70
Large-scale testing (Phase 3)Study completedNCT02460419
What this trial is testing

Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 104
Not applicableStudy completedNCT05524025
What this trial is testing

The SPOT-HPV Study

Who this might be right for
HPV InfectionHPV Positive Oropharyngeal Squamous Cell Carcinoma
Dana-Farber Cancer Institute 360
Not applicableStudy completedNCT05497947
What this trial is testing

Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomy

Who this might be right for
Pharyngeal CancerSwallowing DisorderLarynx Cancer
Centre Hospitalier de Valence 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT05108870
What this trial is testing

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Who this might be right for
Human Papilloma VirusHPVHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
University of Chicago 35
Not applicableStudy completedNCT06244394
What this trial is testing

Retrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRadiation-Induced Temporal Lobe Injury
Jiangsu Cancer Institute & Hospital 230
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303283
What this trial is testing

Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Locoregionally Advanced Nasopharyngeal CarcinomaAdjuvant Therapy
Kai Hu 140
Testing effectiveness (Phase 2)UnknownNCT04586088
What this trial is testing

Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure

Who this might be right for
Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more
Sun Yat-sen University 58
Early research (Phase 1)Ended earlyNCT03144661
What this trial is testing

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal Cancer+3 more
Incyte Corporation 25
Testing effectiveness (Phase 2)UnknownNCT04870905
What this trial is testing

Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 100
Testing effectiveness (Phase 2)UnknownNCT05955105
What this trial is testing

ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Who this might be right for
Head and Neck CancerCervical CancerEndometrial Cancer+7 more
Innolake Biopharm 200
Not applicableLooking for participantsNCT06287788
What this trial is testing

A Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis

Who this might be right for
Radiation-induced Oropharyngeal MucositisSwallowing-induced Breakthrough Pain
Nanfang Hospital, Southern Medical University 240
Not applicableStudy completedNCT07180173
What this trial is testing

Upfront Neck Dissection Before Radiotherapy in Stage N3 Nasopharyngeal Carcinoma: A Retrospective Study

Who this might be right for
OncologyRadiology
Taichung Veterans General Hospital 7
Very early researchLooking for participantsNCT05587543
What this trial is testing

Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 24
Testing effectiveness (Phase 2)Study completedNCT00565448
What this trial is testing

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Who this might be right for
Nasopharyngeal NeoplasmsCarcinoma
Sanofi 75
Large-scale testing (Phase 3)Looking for participantsNCT07188584
What this trial is testing

Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen 166
Not applicableStudy completedNCT00019201
What this trial is testing

Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Looking for participantsNCT04436965
What this trial is testing

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

Who this might be right for
Nasopharyngeal CarcinomaNutrition Therapy
Sun Yat-sen University 266
Testing effectiveness (Phase 2)Active Not RecruitingNCT01898494
What this trial is testing

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

Who this might be right for
Human Papilloma Virus InfectionStage III Squamous Cell Carcinoma of the OropharynxStage IVA Squamous Cell Carcinoma of the Oropharynx+1 more
ECOG-ACRIN Cancer Research Group 519
Testing effectiveness (Phase 2)Looking for participantsNCT03215719
What this trial is testing

Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma

Who this might be right for
Oropharyngeal CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
NYU Langone Health 120
Next Page